Apr 01,2015

Healthcare Startup Noom Raises $16.15M Series B To Expand Its Personalized Coaching Platform

Noom, a mobile healthcare startup that focuses on using data to prevent diseases, announced today that it has raised a $16.15 million Series B.The round was led by InterVest Co Ltd, a South Korea venture capital firm, with participation from LB Investment, Hanmi IT, RRE Ventures, TransLink Capital, and Qualcomm Ventures. Noom raised its $7 million Series A in February 2014 and has also received grants from organizations including the National Institutes of Health (NIH).

FUNDING SERIES B

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
May 21,2015

Eli Lilly invests in smartphone-connected insulin pen startup

San Diego, California-based Companion Medical, a stealthy medical device startup developing a Bluetooth-connected insulin pen and connected app, has closed its second round of funding, led by Eli Lilly and Company. The funding amount was not disclosed.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 17,2015

WellDoc raises $22M for its BlueStar mobile-enabled diabetes management offering

Baltimore, Maryland-based WellDoc has raised $22 million in a round led by Samsung Ventures and Merck Global Health Innovation (GHI) Fund with participation from Adage Capital Management, Excel Venture Management, Alexandria Venture Investments and Hudson River Capital Partners.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 04,2022

Sidekick Health grabs $55M for digital-first care programs

Iceland’s Sidekick Health has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis — a formula that’s now scored it $55 million in Series B growth funding.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 06,2021

Liva Healthcare secures access to €24.5m funding – led by Verlinvest and supported by the existing investors

Liva Healthcare (“Liva”), a European market leader in scalable digital health coaching, has secured a new funding round with access to EUR 24.5 million, led by Verlinvest, the go-to investor for mission-driven entrepreneurs and category-defining global consumer brands. 

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Aug 16,2021

Ultrahuman raises $17.5M, touting a wearable blood glucose tracker

Fitness platform using glucose biomarkers, Ultrahuman, has officially announced a $17.5 million Series B fundraise, with investment coming from early stage fund Alpha Wave Incubation, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Oct 04,2021

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s approach: to monitor key metrics in the body, like glucose, without breaking the skin at all.

FUNDING SERIES B

#rpm

View Analyst & Ambassador Comments
Go to original news
Dec 02,2021

Digital Insulin Management Company Hygieia Closes on $17 Million Series B Investment Round

Funding will enable expansion of company’s AI-driven d-Nav technology, which automates real-time insulin dose recommendations for people with type 2 diabetes. Hygieia, a digital health company for insulin management, has closed on an initial $17 million Series B investment round, led by Israeli venture capital firm Firstime Ventures, and with participation from existing investors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 14,2020

Oviva scores $21M Series B to bring its digital diabetes treatment to more of Europe

Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 27,2020

Babylon Health leads a $30M Series B in US health kiosk operator, Higi

UK-based AI chatbot Babylon Health — which last year raised $550M at a $2BN+ valuation — has led a $30M Series B in US-based Higi, which owns and operates 10,000+ FDA-cleared health kiosks. Higi kiosks have been used by 62M people in North America to date, conducting more than 372M biometric tests. Babylon’s investment in the company will go on supporting the expansion and “enhancement” of this network and it will broaden company's clinical capabilities and ability to support consumers with acute medical problems or those with chronic conditions like hypertension, diabetes, and obesity, thereby allowing Higi to better meet the needs of payors, retailers and health systems.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B